| pubmed-article:17483538 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17483538 | lifeskim:mentions | umls-concept:C0018787 | lld:lifeskim |
| pubmed-article:17483538 | lifeskim:mentions | umls-concept:C0002986 | lld:lifeskim |
| pubmed-article:17483538 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:17483538 | lifeskim:mentions | umls-concept:C0038951 | lld:lifeskim |
| pubmed-article:17483538 | lifeskim:mentions | umls-concept:C1280464 | lld:lifeskim |
| pubmed-article:17483538 | lifeskim:mentions | umls-concept:C1512888 | lld:lifeskim |
| pubmed-article:17483538 | pubmed:issue | 10 | lld:pubmed |
| pubmed-article:17483538 | pubmed:dateCreated | 2007-5-21 | lld:pubmed |
| pubmed-article:17483538 | pubmed:abstractText | Anderson-Fabry disease (AFD) is an uncommon X-linked disorder caused by deficient activity of the lysosomal enzyme alpha-galactosidase A. The Fabry Outcome Survey is a European database designed to monitor the long-term efficacy and safety of enzyme replacement therapy (ERT) with agalsidase alfa. The aim of this study was to determine the prevalence and characteristics of cardiac disease in AFD patients. | lld:pubmed |
| pubmed-article:17483538 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17483538 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17483538 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17483538 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17483538 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17483538 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17483538 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17483538 | pubmed:month | May | lld:pubmed |
| pubmed-article:17483538 | pubmed:issn | 0195-668X | lld:pubmed |
| pubmed-article:17483538 | pubmed:author | pubmed-author:Sunder-Plassm... | lld:pubmed |
| pubmed-article:17483538 | pubmed:author | pubmed-author:MehtaAtulA | lld:pubmed |
| pubmed-article:17483538 | pubmed:author | pubmed-author:ElliottPerry... | lld:pubmed |
| pubmed-article:17483538 | pubmed:author | pubmed-author:BeckMichaelM | lld:pubmed |
| pubmed-article:17483538 | pubmed:author | pubmed-author:KampmannChris... | lld:pubmed |
| pubmed-article:17483538 | pubmed:author | pubmed-author:LinhartAlesA | lld:pubmed |
| pubmed-article:17483538 | pubmed:author | pubmed-author:ZamoranoJosé... | lld:pubmed |
| pubmed-article:17483538 | pubmed:author | pubmed-author:European... | lld:pubmed |
| pubmed-article:17483538 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17483538 | pubmed:volume | 28 | lld:pubmed |
| pubmed-article:17483538 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17483538 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17483538 | pubmed:pagination | 1228-35 | lld:pubmed |
| pubmed-article:17483538 | pubmed:meshHeading | pubmed-meshheading:17483538... | lld:pubmed |
| pubmed-article:17483538 | pubmed:meshHeading | pubmed-meshheading:17483538... | lld:pubmed |
| pubmed-article:17483538 | pubmed:meshHeading | pubmed-meshheading:17483538... | lld:pubmed |
| pubmed-article:17483538 | pubmed:meshHeading | pubmed-meshheading:17483538... | lld:pubmed |
| pubmed-article:17483538 | pubmed:meshHeading | pubmed-meshheading:17483538... | lld:pubmed |
| pubmed-article:17483538 | pubmed:meshHeading | pubmed-meshheading:17483538... | lld:pubmed |
| pubmed-article:17483538 | pubmed:meshHeading | pubmed-meshheading:17483538... | lld:pubmed |
| pubmed-article:17483538 | pubmed:meshHeading | pubmed-meshheading:17483538... | lld:pubmed |
| pubmed-article:17483538 | pubmed:meshHeading | pubmed-meshheading:17483538... | lld:pubmed |
| pubmed-article:17483538 | pubmed:meshHeading | pubmed-meshheading:17483538... | lld:pubmed |
| pubmed-article:17483538 | pubmed:meshHeading | pubmed-meshheading:17483538... | lld:pubmed |
| pubmed-article:17483538 | pubmed:meshHeading | pubmed-meshheading:17483538... | lld:pubmed |
| pubmed-article:17483538 | pubmed:meshHeading | pubmed-meshheading:17483538... | lld:pubmed |
| pubmed-article:17483538 | pubmed:meshHeading | pubmed-meshheading:17483538... | lld:pubmed |
| pubmed-article:17483538 | pubmed:meshHeading | pubmed-meshheading:17483538... | lld:pubmed |
| pubmed-article:17483538 | pubmed:meshHeading | pubmed-meshheading:17483538... | lld:pubmed |
| pubmed-article:17483538 | pubmed:meshHeading | pubmed-meshheading:17483538... | lld:pubmed |
| pubmed-article:17483538 | pubmed:meshHeading | pubmed-meshheading:17483538... | lld:pubmed |
| pubmed-article:17483538 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17483538 | pubmed:articleTitle | Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey. | lld:pubmed |
| pubmed-article:17483538 | pubmed:affiliation | Second Department of Internal Medicine, First Faculty of Medicine, Charles University, Prague, Czech Republic. alinh@lf1.cuni.cz | lld:pubmed |
| pubmed-article:17483538 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17483538 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:17483538 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17483538 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17483538 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17483538 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17483538 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17483538 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17483538 | lld:pubmed |
